Third-party litigation funding is easy to describe and hard to generalise about. In its basic form, an investor who is not a party to a dispute provides money so a claim can be pursued, and is repaid out of the proceeds only if the claim succeeds. The same arrangement that lets someone without savings afford to enforce a right also gives an outside investor a financial stake in the outcome of someone else’s case.
That is why the practice attracts two different framings. One treats it as a practical route to access to justice: a way for individuals, small businesses, and even large companies to pursue a claim without tying up their own capital. The other treats it as a financial product that raises questions about control, disclosure, and cost. Which framing is closer to the truth depends less on the concept itself than on how a particular agreement is written and how the jurisdiction hearing the case supervises it.
This article covers the mechanics, the two main markets, what independent research has found, and where the rules are heading. It is general information rather than legal advice; the terms that apply to any specific case depend on the contract, the forum, and local law.
What third-party litigation funding actually is
Legal reference material defines litigation funding as an arrangement in which a person or firm that is independent of both the claimant and their lawyer provides capital to cover some or all of the costs of a dispute, in exchange for a return that is contingent on the outcome. The funder is not a party to the case and does not replace the lawyer.
Two features matter for understanding the product. The first is that it is usually structured as non-recourse financing: the funder is paid from the proceeds of the litigation, and if the claim fails, the funder typically recovers nothing. Because the whole investment can be lost, funders assess cases in detail before committing, weighing the legal merits, the likely recovery, and how long the case may take to resolve.
The second is that the label covers very different deals. The same term describes a cash advance to an injured person waiting on a personal injury claim and a multi-million-dollar facility for a law firm running a portfolio of commercial cases. Treating those as one product is the most common source of confusion in the public debate.
The money is not a loan, and that changes the risk
Consumer-facing funding is often marketed and regulated differently from lending, and the distinction is not just semantics. In a conventional loan, the borrower owes repayment whether or not the underlying venture succeeds. In a non-recourse advance, the obligation is tied to the claim, so a claimant who loses generally owes nothing.
How a transaction is legally characterised varies. Some arrangements sit close to a loan, with the litigation proceeds acting as collateral. Others are framed as a purchase of a share of future proceeds. Courts and tax authorities in different countries have taken different positions, and the classification can affect tax treatment, enforceability, and which regulator has oversight. Industry surveys note that this uncertainty is one reason funding agreements are drafted carefully around existing legal categories rather than treated casually.
Commercial and consumer funding are different products
Most market commentary splits the field in two. Commercial funding supports businesses and law firms in disputes that are often complex and expensive, from antitrust and intellectual property to arbitration and enforcement. Consumer legal funding typically supports individuals with pending claims, and the money is often used for day-to-day living expenses while a case is resolved. A third structure, portfolio funding, provides capital to a law firm against a group of cases rather than a single matter.
| Commercial litigation funding | Consumer legal funding | |
|---|---|---|
| Typical funded party | Businesses, law firms, and other organisations with commercial claims | Individuals with a pending civil or injury claim |
| What the advance covers | Legal fees, expert costs, and other case expenses | Often living expenses while the claim is pending |
| Repayment | Generally non-recourse from case proceeds, on terms set by the contract | Generally non-recourse; several U.S. states cap charges by statute |
| Where rules focus | Court disclosure, conflicts of interest, and control of litigation | State licensing, mandatory disclosures, cancellation rights, and fee caps |
Compiled from an overview of litigation funding published by the International Comparative Legal Guides (July 2026), the Solicitors Regulation Authority’s third-party funding guidance (2026), and U.S. state consumer funding statutes.
Does funding really expand access to justice? The evidence is mixed
The most-cited independent study on this question was commissioned by the Legal Services Board and carried out at Queen Mary University of London, with findings published in 2024. It concluded that litigation funding does allow individuals, small and medium-sized businesses, and corporations to pursue claims they would otherwise be unable or unwilling to self-fund.
The same research added two important caveats. Funders select only a small minority of the cases brought to them – the study put the figure at roughly 3% to 5% – so funding cannot currently serve as a mainstream route to justice on its own. And even where funding enables a claim to proceed, the study noted that the amount a claimant ultimately receives can be too small to address the full harm suffered, particularly when further costs must be covered. You can read the summary of that research on litigation funding and access to justice.
That combination – real but selective benefit – is the honest state of the evidence. Funding is not a substitute for legal aid, and it is not a universal fix for the cost of litigation. It is one tool among several, including legal expenses insurance, conditional fee agreements, and damages-based agreements, each with its own trade-offs.
What regulators are actually worried about
The regulatory debate is narrower than the public one. It focuses on three practical issues rather than on whether funding should exist at all.
Disclosure. Because many courts do not require parties to reveal that a claim is funded, judges, defendants, and sometimes claimants themselves may not know who has a financial interest in a case. A 2026 Chambers practice guide described disclosure as the most active regulatory issue globally in 2025, with courts and policymakers increasingly treating it as a proportionate way to manage conflicts without restricting access to capital. Approaches still differ widely by jurisdiction.
Control and conflicts. Professional conduct rules in several jurisdictions require that the client and their lawyer – not the funder – retain control of litigation strategy and settlement decisions. Funding agreements may nonetheless give a funder consultation rights or a degree of influence over whether a settlement is accepted, which is why regulators focus on conflict management rather than on the existence of funding itself.
Transparency in specific contexts. In patent litigation, the U.S. Government Accountability Office reported in 2025 that stakeholders saw a significant rise in third-party funded cases since 2019, and that most of the large technology companies it interviewed said more than half of the patent infringement suits filed against them had confirmed or suspected funding. The same report noted that, because most courts do not require disclosure, the true extent is difficult to measure. You can read the GAO’s report on third-party funding of patent litigation.
Where the money goes, and who decides
Funding agreements commonly set out a payment waterfall that determines the order in which any recovery is distributed. The sequence is negotiated case by case and varies widely. In a typical plaintiff-side arrangement, the funder’s advance and agreed return are discharged from the proceeds, and the remaining balance is distributed under the client’s fee agreement and paid to the client. Where a lawyer is working on a contingency basis, their fee also comes out of the recovery.
The percentage, multiple, or fixed sum a funder receives differs by jurisdiction, case type, and contract. It is not a standard rate, and treating any single figure as universal would be misleading. What is consistent is that the terms are spelled out in the contract, and reading that contract closely is the main protection available to a funded party.
The rules depend on where the case is heard
There is no single global framework. A 2026 cross-border survey described third-party funding regulation as limited in most jurisdictions, with the United States developing rules through local court orders and state statutes rather than comprehensive federal legislation, and Europe proceeding cautiously.
| Jurisdiction | Direction of travel (as of mid-2026) |
|---|---|
| England and Wales | Funding is permitted and largely self-regulated, alongside professional rules for solicitors. A Civil Justice Council review published in June 2025 recommended a “light-touch” statutory framework with disclosure duties; the government signalled limited reforms in December 2025. |
| United States | No uniform federal rule. Disclosure is imposed through a patchwork of local court rules, standing orders, and state statutes, with several states regulating consumer funding directly. |
| European Union | The European Parliament backed a proposed regulation in 2022, but the European Commission declined to adopt it in November 2025 and continues to monitor the market. |
Sources: International Comparative Legal Guides (July 2026), Chambers Litigation Funding 2026 guide, and WilmerHale’s 2026 review of third-party litigation funding trends.
Regulatory attention has followed the market’s growth. In England and Wales, the Civil Justice Council’s June 2025 report recommended disclosure of the fact of funding, the identity of the funder, and the ultimate source of the money, together with legislation to reverse the effect of the 2023 PACCAR Supreme Court decision on funding agreements. The UK government indicated in December 2025 that it intended to bring forward limited reforms, although no bill had been placed before Parliament at the time of writing. Coverage of developments in the legal sector such as these is useful context for anyone tracking how disclosure duties are likely to evolve.
On the consumer side, several U.S. states have moved ahead independently. California’s Consumer Legal Funding Act requires written contracts, a five-business-day right to cancel, disclosure of the maximum total a consumer could owe, and time-based charges that run no longer than 36 months from the funding date. You can read the text of California’s consumer legal funding statute. New York has taken a different route, placing oversight with its Department of Financial Services and capping what a funder can collect at the funded amount plus 25% of the proceeds, with the core contract rules applying to agreements made on or after 17 June 2026.
In the UK, the Solicitors Regulation Authority has consulted on new requirements for law firms that use or arrange funding for consumer claims, including a prescribed information document for clients, notification to the regulator, and documented risk assessments. None of these changes have abolished funding; they aim to make its terms visible and its conflicts manageable.
What to check before you sign
For anyone considering a funding agreement, the practical questions are consistent across jurisdictions, even where the rules are not.
- Is the arrangement non-recourse, and is that stated plainly? Confirm what happens if the claim fails and whether any obligation survives.
- What is the maximum you could owe, in pounds, dollars, or euros – not as a rate? A total figure is easier to reason about than an accruing charge.
- How are charges calculated over time? Some jurisdictions require a schedule; others rely on the contract.
- Who decides whether to settle? Under professional rules the client and lawyer should retain that decision, but the agreement may include consultation rights.
- What information must you share, and is it protected? Privilege and confidentiality treatment varies, and non-disclosure agreements are common in commercial deals.
- Can you cancel, and within what period? Some consumer statutes provide a cancellation window; commercial agreements may not.
- What happens if several funders are involved? Some rules require written consent before obligations stack on the same recovery.
If a claim later settles, the order in which the money is distributed will follow the waterfall in the agreement. Understanding that order in advance, rather than after a settlement, is the single most useful step a funded party can take.
Frequently asked questions
Is third-party litigation funding a loan?
Usually not in substance. Most plaintiff-side funding is non-recourse, meaning repayment depends on the outcome and comes from the proceeds. Some arrangements are structured closer to a loan, and the legal characterisation varies by jurisdiction, which can affect tax and enforceability.
Do I have to repay if I lose the case?
Under a standard non-recourse agreement, generally no. But portfolio or recourse funding, where a law firm repays regardless of individual case outcomes, works differently. The contract is the decisive document.
Does a funder control my lawsuit?
Professional conduct rules in several jurisdictions require the client and their lawyer to control litigation and settlement decisions. Funding agreements may still create consultation rights or influence, which is precisely why regulators emphasise conflict management and disclosure.
How much can a funder take?
It depends on the jurisdiction and the contract. Some U.S. states cap consumer charges by statute, while commercial terms are freely negotiated and vary widely. There is no single industry-wide percentage.
Is my case information confidential once a funder is involved?
Funders typically need case information to assess and monitor a claim. Privilege and work-product protections apply differently across courts, so non-disclosure agreements and careful handling of documents are common practice.
Is litigation funding legal everywhere?
No. Historically, many common law jurisdictions restricted it through the doctrines of maintenance and champerty. Those prohibitions have been relaxed in many places, but some countries still restrict or prohibit the practice, so the answer depends on where the case is heard.
How this article was put together
This explainer set out to answer a narrow question: how third-party litigation funding works, what the evidence says about its effect on access to justice, and how it is regulated. It draws on a 2024 academic study commissioned by the Legal Services Board and carried out at Queen Mary University of London, reports from the U.S. Government Accountability Office, the U.S. state consumer funding statutes cited above, and 2026 market and regulatory reviews from legal reference publishers and law firms. Figures were checked in September 2026. Where sources disagree – particularly on how funding should be characterised and on how large the market is – the text says so. Regulation in this area is changing quickly, so recheck the position in the relevant jurisdiction before relying on any rule described here.
This article provides general information and does not constitute legal advice.
